Europe Anti-Obesity Drug Market Report 2016

Publisher Name :
Date: 12-Oct-2016
No. of pages: 111
Inquire Before Buying

Notes:

Sales, means the sales volume of Anti-Obesity Drug

Revenue, means the sales value of Anti-Obesity Drug

This report studies sales (consumption) of Anti-Obesity Drug in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

- Pfizer

- Merck

- F. Hoffmann-La Roche

- GlaxoSmithKline

- AstraZeneca

- Boehringer Ingelheim

- Novo Nordisk

- Eisai

- Norgine

- Arena Pharmaceuticals

- Orexigen Therapeutics

- Vivus

- Alizyme

- Rhythm Pharmaceuticals

- Shionogi

- Zafgan

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Anti-Obesity Drug in these countries, from 2011 to 2021 (forecast), like

- Germany

- France

- UK

- Russia

- Italy

- Spain

- Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by application, this report focuses on sales, market share and growth rate of Anti-Obesity Drug in each application, can be divided into

- Application 1

- Application 2

- Application 3

Europe Anti-Obesity Drug Market Report 2016

Table of Contents
Europe Anti-Obesity Drug Market Report 2016
1 Anti-Obesity Drug Overview
1.1 Product Overview and Scope of Anti-Obesity Drug
1.2 Classification of Anti-Obesity Drug
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Anti-Obesity Drug
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Anti-Obesity Drug Market by Countries
1.4.1 Germany Status and Prospect (2011-2021)
1.4.2 France Status and Prospect (2011-2021)
1.4.3 UK Status and Prospect (2011-2021)
1.4.4 Russia Status and Prospect (2011-2021)
1.4.5 Italy Status and Prospect (2011-2021)
1.4.6 Spain Status and Prospect (2011-2021)
1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Anti-Obesity Drug (2011-2021)
1.5.1 Europe Anti-Obesity Drug Sales and Growth Rate (2011-2021)
1.5.2 Europe Anti-Obesity Drug Revenue and Growth Rate (2011-2021)
2 Europe Anti-Obesity Drug by Manufacturers, Type and Application
2.1 Europe Anti-Obesity Drug Market Competition by Manufacturers
2.1.1 Europe Anti-Obesity Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Anti-Obesity Drug Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Anti-Obesity Drug (Volume and Value) by Type
2.2.1 Europe Anti-Obesity Drug Sales and Market Share by Type (2011-2016)
2.2.2 Europe Anti-Obesity Drug Revenue and Market Share by Type (2011-2016)
2.3 Europe Anti-Obesity Drug (Volume and Value) by Countries
2.3.1 Europe Anti-Obesity Drug Sales and Market Share by Countries (2011-2016)
2.3.2 Europe Anti-Obesity Drug Revenue and Market Share by Countries (2011-2016)
2.4 Europe Anti-Obesity Drug (Volume) by Application
3 Germany Anti-Obesity Drug (Volume, Value and Sales Price)
3.1 Germany Anti-Obesity Drug Sales and Value (2011-2016)
3.1.1 Germany Anti-Obesity Drug Sales and Growth Rate (2011-2016)
3.1.2 Germany Anti-Obesity Drug Revenue and Growth Rate (2011-2016)
3.1.3 Germany Anti-Obesity Drug Sales Price Trend (2011-2016)
3.2 Germany Anti-Obesity Drug Sales and Market Share by Manufacturers
3.3 Germany Anti-Obesity Drug Sales and Market Share by Type
3.4 Germany Anti-Obesity Drug Sales and Market Share by Application
4 France Anti-Obesity Drug (Volume, Value and Sales Price)
4.1 France Anti-Obesity Drug Sales and Value (2011-2016)
4.1.1 France Anti-Obesity Drug Sales and Growth Rate (2011-2016)
4.1.2 France Anti-Obesity Drug Revenue and Growth Rate (2011-2016)
4.1.4 France Anti-Obesity Drug Sales Price Trend (2011-2016)
4.2 France Anti-Obesity Drug Sales and Market Share by Manufacturers
4.3 France Anti-Obesity Drug Sales and Market Share by Type
4.4 France Anti-Obesity Drug Sales and Market Share by Application
5 UK Anti-Obesity Drug (Volume, Value and Sales Price)
5.1 UK Anti-Obesity Drug Sales and Value (2011-2016)
5.1.1 UK Anti-Obesity Drug Sales and Growth Rate (2011-2016)
5.1.2 UK Anti-Obesity Drug Revenue and Growth Rate (2011-2016)
5.1.5 UK Anti-Obesity Drug Sales Price Trend (2011-2016)
5.2 UK Anti-Obesity Drug Sales and Market Share by Manufacturers
5.3 UK Anti-Obesity Drug Sales and Market Share by Type
5.4 UK Anti-Obesity Drug Sales and Market Share by Application
6 Russia Anti-Obesity Drug (Volume, Value and Sales Price)
6.1 Russia Anti-Obesity Drug Sales and Value (2011-2016)
6.1.1 Russia Anti-Obesity Drug Sales and Growth Rate (2011-2016)
6.1.2 Russia Anti-Obesity Drug Revenue and Growth Rate (2011-2016)
6.1.6 Russia Anti-Obesity Drug Sales Price Trend (2011-2016)
6.2 Russia Anti-Obesity Drug Sales and Market Share by Manufacturers
6.3 Russia Anti-Obesity Drug Sales and Market Share by Type
6.4 Russia Anti-Obesity Drug Sales and Market Share by Application
7 Italy Anti-Obesity Drug (Volume, Value and Sales Price)
7.1 Italy Anti-Obesity Drug Sales and Value (2011-2016)
7.1.1 Italy Anti-Obesity Drug Sales and Growth Rate (2011-2016)
7.1.2 Italy Anti-Obesity Drug Revenue and Growth Rate (2011-2016)
7.1.7 Italy Anti-Obesity Drug Sales Price Trend (2011-2016)
7.2 Italy Anti-Obesity Drug Sales and Market Share by Manufacturers
7.3 Italy Anti-Obesity Drug Sales and Market Share by Type
7.4 Italy Anti-Obesity Drug Sales and Market Share by Application
8 Spain Anti-Obesity Drug (Volume, Value and Sales Price)
8.1 Spain Anti-Obesity Drug Sales and Value (2011-2016)
8.1.1 Spain Anti-Obesity Drug Sales and Growth Rate (2011-2016)
8.1.2 Spain Anti-Obesity Drug Revenue and Growth Rate (2011-2016)
8.1.8 Spain Anti-Obesity Drug Sales Price Trend (2011-2016)
8.2 Spain Anti-Obesity Drug Sales and Market Share by Manufacturers
8.3 Spain Anti-Obesity Drug Sales and Market Share by Type
8.4 Spain Anti-Obesity Drug Sales and Market Share by Application
9 Benelux Anti-Obesity Drug (Volume, Value and Sales Price)
9.1 Benelux Anti-Obesity Drug Sales and Value (2011-2016)
9.1.1 Benelux Anti-Obesity Drug Sales and Growth Rate (2011-2016)
9.1.2 Benelux Anti-Obesity Drug Revenue and Growth Rate (2011-2016)
9.1.9 Benelux Anti-Obesity Drug Sales Price Trend (2011-2016)
9.2 Benelux Anti-Obesity Drug Sales and Market Share by Manufacturers
9.3 Benelux Anti-Obesity Drug Sales and Market Share by Type
9.4 Benelux Anti-Obesity Drug Sales and Market Share by Application
10 Europe Anti-Obesity Drug Manufacturers Analysis
10.1 Pfizer
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Anti-Obesity Drug Product Type, Application and Specification
10.1.2.1 Type I
10.1.2.2 Type II
10.1.3 Pfizer Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.1.4 Main Business/Business Overview
10.2 Merck
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Anti-Obesity Drug Product Type, Application and Specification
10.2.2.1 Type I
10.2.2.2 Type II
10.2.3 Merck Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.2.4 Main Business/Business Overview
10.3 F. Hoffmann-La Roche
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Anti-Obesity Drug Product Type, Application and Specification
10.3.2.1 Type I
10.3.2.2 Type II
10.3.3 F. Hoffmann-La Roche Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.3.4 Main Business/Business Overview
10.4 GlaxoSmithKline
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Anti-Obesity Drug Product Type, Application and Specification
10.4.2.1 Type I
10.4.2.2 Type II
10.4.3 GlaxoSmithKline Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.4.4 Main Business/Business Overview
10.5 AstraZeneca
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Anti-Obesity Drug Product Type, Application and Specification
10.5.2.1 Type I
10.5.2.2 Type II
10.5.3 AstraZeneca Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.5.4 Main Business/Business Overview
10.6 Boehringer Ingelheim
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Anti-Obesity Drug Product Type, Application and Specification
10.6.2.1 Type I
10.6.2.2 Type II
10.6.3 Boehringer Ingelheim Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.6.4 Main Business/Business Overview
10.7 Novo Nordisk
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Anti-Obesity Drug Product Type, Application and Specification
10.7.2.1 Type I
10.7.2.2 Type II
10.7.3 Novo Nordisk Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.7.4 Main Business/Business Overview
10.8 Eisai
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Anti-Obesity Drug Product Type, Application and Specification
10.8.2.1 Type I
10.8.2.2 Type II
10.8.3 Eisai Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.8.4 Main Business/Business Overview
10.9 Norgine
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Anti-Obesity Drug Product Type, Application and Specification
10.9.2.1 Type I
10.9.2.2 Type II
10.9.3 Norgine Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.9.4 Main Business/Business Overview
10.10 Arena Pharmaceuticals
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Anti-Obesity Drug Product Type, Application and Specification
10.10.2.1 Type I
10.10.2.2 Type II
10.10.3 Arena Pharmaceuticals Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.10.4 Main Business/Business Overview
10.11 Orexigen Therapeutics
10.12 Vivus
10.13 Alizyme
10.14 Rhythm Pharmaceuticals
10.15 Shionogi
10.16 Zafgan
11 Anti-Obesity Drug Manufacturing Cost Analysis
11.1 Anti-Obesity Drug Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Anti-Obesity Drug
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Anti-Obesity Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Anti-Obesity Drug Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe Anti-Obesity Drug Market Forecast (2016-2021)
14.1 Germany Anti-Obesity Drug Sales Forecast (2016-2021)
14.2 France Anti-Obesity Drug Sales Forecast (2016-2021)
14.3 UK Anti-Obesity Drug Sales Forecast (2016-2021)
14.4 Russia Anti-Obesity Drug Sales Forecast (2016-2021)
14.5 Italy Anti-Obesity Drug Sales Forecast (2016-2021)
14.6 Spain Anti-Obesity Drug Sales Forecast (2016-2021)
14.7 Benelux Anti-Obesity Drug Sales Forecast (2016-2021)
14.8 Europe Anti-Obesity Drug Sales Forecast by Type (2016-2021)
14.9 Europe Anti-Obesity Drug Sales Forecast by Application (2016-2021)
15 Research Findings and Conclusion
16 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Anti-Obesity Drug
Table Classification of Anti-Obesity Drug
Figure Europe Sales Market Share of Anti-Obesity Drug by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Anti-Obesity Drug
Figure Europe Sales Market Share of Anti-Obesity Drug by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Anti-Obesity Drug Revenue and Growth Rate (2011-2021)
Figure France Anti-Obesity Drug Revenue and Growth Rate (2011-2021)
Figure UK Anti-Obesity Drug Revenue and Growth Rate (2011-2021)
Figure Russia Anti-Obesity Drug Revenue and Growth Rate (2011-2021)
Figure Italy Anti-Obesity Drug Revenue and Growth Rate (2011-2021)
Figure Spain Anti-Obesity Drug Revenue and Growth Rate (2011-2021)
Figure Benelux Anti-Obesity Drug Revenue and Growth Rate (2011-2021)
Figure Europe Anti-Obesity Drug Sales and Growth Rate (2011-2021)
Figure Europe Anti-Obesity Drug Revenue and Growth Rate (2011-2021)
Table Europe Anti-Obesity Drug Sales of Key Manufacturers (2015 and 2016)
Table Europe Anti-Obesity Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Anti-Obesity Drug Sales Share by Manufacturers
Figure 2016 Anti-Obesity Drug Sales Share by Manufacturers
Table Europe Anti-Obesity Drug Revenue by Manufacturers (2015 and 2016)
Table Europe Anti-Obesity Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Anti-Obesity Drug Revenue Share by Manufacturers
Table 2016 Europe Anti-Obesity Drug Revenue Share by Manufacturers
Table Europe Anti-Obesity Drug Sales and Market Share by Type (2011-2016)
Table Europe Anti-Obesity Drug Sales Share by Type (2011-2016)
Figure Sales Market Share of Anti-Obesity Drug by Type (2011-2016)
Figure Europe Anti-Obesity Drug Sales Growth Rate by Type (2011-2016)
Table Europe Anti-Obesity Drug Revenue and Market Share by Type (2011-2016)
Table Europe Anti-Obesity Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Anti-Obesity Drug by Type (2011-2016)
Figure Europe Anti-Obesity Drug Revenue Growth Rate by Type (2011-2016)
Table Europe Anti-Obesity Drug Sales and Market Share by Countries (2011-2016)
Table Europe Anti-Obesity Drug Sales Share by Countries (2011-2016)
Figure Sales Market Share of Anti-Obesity Drug by Countries (2011-2016)
Table Europe Anti-Obesity Drug Revenue and Market Share by Countries (2011-2016)
Table Europe Anti-Obesity Drug Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Anti-Obesity Drug by Countries (2011-2016)
Table Europe Anti-Obesity Drug Sales and Market Share by Application (2011-2016)
Table Europe Anti-Obesity Drug Sales Share by Application (2011-2016)
Figure Sales Market Share of Anti-Obesity Drug by Application (2011-2016)
Figure Germany Anti-Obesity Drug Sales and Growth Rate (2011-2016)
Figure Germany Anti-Obesity Drug Revenue and Growth Rate (2011-2016)
Figure Germany Anti-Obesity Drug Sales Price Trend (2011-2016)
Table Germany Anti-Obesity Drug Sales by Manufacturers (2015 and 2016)
Table Germany Anti-Obesity Drug Market Share by Manufacturers (2015 and 2016)
Table Germany Anti-Obesity Drug Sales by Type (2015 and 2016)
Table Germany Anti-Obesity Drug Market Share by Type (2015 and 2016)
Table Germany Anti-Obesity Drug Sales by Application (2015 and 2016)
Table Germany Anti-Obesity Drug Market Share by Application (2015 and 2016)
Figure France Anti-Obesity Drug Sales and Growth Rate (2011-2016)
Figure France Anti-Obesity Drug Revenue and Growth Rate (2011-2016)
Figure France Anti-Obesity Drug Sales Price Trend (2011-2016)
Table France Anti-Obesity Drug Sales by Manufacturers (2015 and 2016)
Table France Anti-Obesity Drug Market Share by Manufacturers (2015 and 2016)
Table France Anti-Obesity Drug Sales by Type (2015 and 2016)
Table France Anti-Obesity Drug Market Share by Type (2015 and 2016)
Table France Anti-Obesity Drug Sales by Application (2015 and 2016)
Table France Anti-Obesity Drug Market Share by Application (2015 and 2016)
Figure UK Anti-Obesity Drug Sales and Growth Rate (2011-2016)
Figure UK Anti-Obesity Drug Revenue and Growth Rate (2011-2016)
Figure UK Anti-Obesity Drug Sales Price Trend (2011-2016)
Table UK Anti-Obesity Drug Sales by Manufacturers (2015 and 2016)
Table UK Anti-Obesity Drug Market Share by Manufacturers (2015 and 2016)
Table UK Anti-Obesity Drug Sales by Type (2015 and 2016)
Table UK Anti-Obesity Drug Market Share by Type (2015 and 2016)
Table UK Anti-Obesity Drug Sales by Application (2015 and 2016)
Table UK Anti-Obesity Drug Market Share by Application (2015 and 2016)
Figure Russia Anti-Obesity Drug Sales and Growth Rate (2011-2016)
Figure Russia Anti-Obesity Drug Revenue and Growth Rate (2011-2016)
Figure Russia Anti-Obesity Drug Sales Price Trend (2011-2016)
Table Russia Anti-Obesity Drug Sales by Manufacturers (2015 and 2016)
Table Russia Anti-Obesity Drug Market Share by Manufacturers (2015 and 2016)
Table Russia Anti-Obesity Drug Sales by Type (2015 and 2016)
Table Russia Anti-Obesity Drug Market Share by Type (2015 and 2016)
Table Russia Anti-Obesity Drug Sales by Application (2015 and 2016)
Table Russia Anti-Obesity Drug Market Share by Application (2015 and 2016)
Figure Italy Anti-Obesity Drug Sales and Growth Rate (2011-2016)
Figure Italy Anti-Obesity Drug Revenue and Growth Rate (2011-2016)
Figure Italy Anti-Obesity Drug Sales Price Trend (2011-2016)
Table Italy Anti-Obesity Drug Sales by Manufacturers (2015 and 2016)
Table Italy Anti-Obesity Drug Market Share by Manufacturers (2015 and 2016)
Table Italy Anti-Obesity Drug Sales by Type (2015 and 2016)
Table Italy Anti-Obesity Drug Market Share by Type (2015 and 2016)
Table Italy Anti-Obesity Drug Sales by Application (2015 and 2016)
Table Italy Anti-Obesity Drug Market Share by Application (2015 and 2016)
Figure Spain Anti-Obesity Drug Sales and Growth Rate (2011-2016)
Figure Spain Anti-Obesity Drug Revenue and Growth Rate (2011-2016)
Figure Spain Anti-Obesity Drug Sales Price Trend (2011-2016)
Table Spain Anti-Obesity Drug Sales by Manufacturers (2015 and 2016)
Table Spain Anti-Obesity Drug Market Share by Manufacturers (2015 and 2016)
Table Spain Anti-Obesity Drug Sales by Type (2015 and 2016)
Table Spain Anti-Obesity Drug Market Share by Type (2015 and 2016)
Table Spain Anti-Obesity Drug Sales by Application (2015 and 2016)
Table Spain Anti-Obesity Drug Market Share by Application (2015 and 2016)
Figure Benelux Anti-Obesity Drug Sales and Growth Rate (2011-2016)
Figure Benelux Anti-Obesity Drug Revenue and Growth Rate (2011-2016)
Figure Benelux Anti-Obesity Drug Sales Price Trend (2011-2016)
Table Benelux Anti-Obesity Drug Sales by Manufacturers (2015 and 2016)
Table Benelux Anti-Obesity Drug Market Share by Manufacturers (2015 and 2016)
Table Benelux Anti-Obesity Drug Sales by Type (2015 and 2016)
Table Benelux Anti-Obesity Drug Market Share by Type (2015 and 2016)
Table Benelux Anti-Obesity Drug Sales by Application (2015 and 2016)
Table Benelux Anti-Obesity Drug Market Share by Application (2015 and 2016)
Table Anti-Obesity Drug Basic Information List
Table Pfizer Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Anti-Obesity Drug Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Anti-Obesity Drug Sales Market Share (2011-2016)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann-La Roche Anti-Obesity Drug Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Anti-Obesity Drug Sales Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca Anti-Obesity Drug Sales Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim Anti-Obesity Drug Sales Market Share (2011-2016)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novo Nordisk Anti-Obesity Drug Sales Market Share (2011-2016)
Table Eisai Basic Information List
Table Eisai Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai Anti-Obesity Drug Sales Market Share (2011-2016)
Table Norgine Basic Information List
Table Norgine Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Norgine Anti-Obesity Drug Sales Market Share (2011-2016)
Table Arena Pharmaceuticals Basic Information List
Table Arena Pharmaceuticals Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Arena Pharmaceuticals Anti-Obesity Drug Sales Market Share (2011-2016)
Table Orexigen Therapeutics Basic Information List
Table Orexigen Therapeutics Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Orexigen Therapeutics Anti-Obesity Drug Sales Market Share (2011-2016)
Table Vivus Basic Information List
Table Vivus Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vivus Anti-Obesity Drug Sales Market Share (2011-2016)
Table Alizyme Basic Information List
Table Alizyme Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alizyme Anti-Obesity Drug Sales Market Share (2011-2016)
Table Rhythm Pharmaceuticals Basic Information List
Table Rhythm Pharmaceuticals Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Rhythm Pharmaceuticals Anti-Obesity Drug Sales Market Share (2011-2016)
Table Shionogi Basic Information List
Table Shionogi Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shionogi Anti-Obesity Drug Sales Market Share (2011-2016)
Table Zafgan Basic Information List
Table Zafgan Anti-Obesity Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zafgan Anti-Obesity Drug Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-Obesity Drug
Figure Manufacturing Process Analysis of Anti-Obesity Drug
Figure Anti-Obesity Drug Industrial Chain Analysis
Table Raw Materials Sources of Anti-Obesity Drug Major Manufacturers in 2015
Table Major Buyers of Anti-Obesity Drug
Table Distributors/Traders List
Figure Germany Anti-Obesity Drug Sales and Growth Rate Forecast (2016-2021)
Figure Germany Anti-Obesity Drug Revenue and Growth Rate Forecast (2016-2021)
Figure France Anti-Obesity Drug Sales and Growth Rate Forecast (2016-2021)
Figure France Anti-Obesity Drug Revenue and Growth Rate Forecast (2016-2021)
Figure UK Anti-Obesity Drug Sales and Growth Rate Forecast (2016-2021)
Figure UK Anti-Obesity Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Anti-Obesity Drug Sales and Growth Rate Forecast (2016-2021)
Figure Russia Anti-Obesity Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Anti-Obesity Drug Sales and Growth Rate Forecast (2016-2021)
Figure Italy Anti-Obesity Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Anti-Obesity Drug Sales and Growth Rate Forecast (2016-2021)
Figure Spain Anti-Obesity Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Anti-Obesity Drug Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Anti-Obesity Drug Revenue and Growth Rate Forecast (2016-2021)
Table Europe Anti-Obesity Drug Sales Forecast by Type (2016-2021)
Table Europe Anti-Obesity Drug Sales Forecast by Application (2016-2021)
  • Global Animal Antimicrobials Market Research Report 2016
    Published: 08-Dec-2016        Price: US 2900 Onwards        Pages: 101
    Notes: Production, means the output of Animal Antimicrobials Revenue, means the sales value of Animal Antimicrobials This report studies Animal Antimicrobials in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Zoetis, Inc. - Boehringer Ingelheim GmbH - Eli Lilly and Company......
  • Global Hemophilia A Drug Market Research Report 2016
    Published: 08-Dec-2016        Price: US 2900 Onwards        Pages: 114
    Notes: Production, means the output of Hemophilia A Drug Revenue, means the sales value of Hemophilia A Drug This report studies Hemophilia A Drug in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Baxter International - Bayer's - CSL Behring - Novo Nordisk - Pf......
  • Global Human Fibrin Sealant Market Research Report 2016
    Published: 08-Dec-2016        Price: US 2900 Onwards        Pages: 100
    Notes: Production, means the output of Human Fibrin Sealant Revenue, means the sales value of Human Fibrin Sealant This report studies Human Fibrin Sealant in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Baxter International - CSL Behring - Johnson & Johnson - Asahi......
  • Global Hemophilia B Drug Market Research Report 2016
    Published: 08-Dec-2016        Price: US 2900 Onwards        Pages: 118
    Notes: Production, means the output of Hemophilia B Drug Revenue, means the sales value of Hemophilia B Drug This report studies Hemophilia B Drug in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Baxter - Grifols - Novo Nordisk - Pfizer - Amarna Therapeutics......
  • Global Neurodegenerative Diseases Drug Market Research Report 2016
    Published: 08-Dec-2016        Price: US 2900 Onwards        Pages: 112
    Notes: Production, means the output of Neurodegenerative Diseases Drug Revenue, means the sales value of Neurodegenerative Diseases Drug This report studies Neurodegenerative Diseases Drug in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Novartis - Merck Serono - Teva Pharm......
  • Global Asthma Treatment Drugs Market Research Report 2016
    Published: 08-Dec-2016        Price: US 2900 Onwards        Pages: 102
    Notes: Production, means the output of Asthma Treatment Drugs Revenue, means the sales value of Asthma Treatment Drugs This report studies Asthma Treatment Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - GlaxoSmithKline - Sanofi - Roche & Novartis - Teva......
  • Global Bio-Electronic Medicine Market Research Report 2016
    Published: 08-Dec-2016        Price: US 2900 Onwards        Pages: 116
    Notes: Production, means the output of Bio-Electronic Medicine Revenue, means the sales value of Bio-Electronic Medicine This report studies Bio-Electronic Medicine in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Bioelectronics Corporation - Avago - Honeywell International......
  • Global Bio-pharma Market Research Report 2016
    Published: 08-Dec-2016        Price: US 2900 Onwards        Pages: 110
    Notes: Production, means the output of Bio-pharma Revenue, means the sales value of Bio-pharma This report studies Bio-pharma in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Pfizer - F. Hoffmann-La Roche AG - Johnson & Johnson Services - Sanofi, Amgen - AbbVi......
  • Global Biotherapeutics Market Research Report 2016
    Published: 08-Dec-2016        Price: US 2900 Onwards        Pages: 104
    Notes: Production, means the output of Biotherapeutics Revenue, means the sales value of Biotherapeutics This report studies Biotherapeutics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Beckman Coulter, Inc. - Boehringer Ingelheim Pharma GmbH & Co KG. - Catalent, Inc.......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs